Breaking News Instant updates and real-time market news.

RNR

RenaissanceRe

$132.41

-1.01 (-0.76%)

08:47
10/02/18
10/02
08:47
10/02/18
08:47

TimeSquare urges RenaissanceRe board to review strategic alternatives

TimesSquare Capital Management, an institutional asset management firm with a significant stake in RenaissanceRe Holdings, announced that it has delivered the following letter to the Company's Board of Directors: "We trust that you and the Board have given serious consideration to the perspectives raised in our letter that was sent on September 7, 2018. We have decided to publicly release this earlier letter in order to outline our views for shareholders and to ensure that our thoughts on maximizing shareholder value are as explicit as possible. We remain steadfast in our belief that an immediate review of strategic alternatives, including an exploration of a potential sale of the Company, is imperative. As always, we appreciate your willingness to engage in dialogue with us and look forward to the efforts of the Board and management to further evaluate pathways to unlock value for the benefit of shareholders."

  • 15

    Oct

RNR RenaissanceRe
$132.41

-1.01 (-0.76%)

01/09/18
WELS
01/09/18
NO CHANGE
Target $125
WELS
Market Perform
RenaissanceRe price target lowered to $125 from $140 at Wells Fargo
Wells Fargo analyst Elyse Greenspan lowered her price target for RenaissanceRe to $125 from $140 to reflect Q4 cats, principally from the California wildfires, and 2018/2019 estimates for tax reform. The analyst reiterates a Market Perform rating on the shares.
06/18/18
GSCO
06/18/18
INITIATION
Target $131
GSCO
Neutral
RenaissanceRe initiated with a Neutral at Goldman Sachs
Goldman Sachs started RenaissanceRe with a Neutral rating and $131 price target.
06/18/18
GSCO
06/18/18
INITIATION
Target $131
GSCO
Neutral
RenaissanceRe initiated with a Neutral at Goldman Sachs
Goldman Sachs analyst Yaron Knar initiated RenaissanceRe with a Neutral and $131 price target saying he has concerns regarding the company's investment portfolio this late in the credit cycle and expects industry property casualty returns to continue to erode.
08/28/18
BUCK
08/28/18
NO CHANGE
BUCK
Buckingham sees RenaissanceRe, Axis Capital trading up on Aspen deal news
Buckingham analyst Amit Kumar called the multiple Apollo Global (APO) agreed to pay to acquire Aspen Insurance (AHL) "a tad underwhelming compared to other recent deals," which he attributes to Aspen's hand being forced by the fast approaching peak hurricane season and investor skepticism on its standalone future. Given the drawn out process, he sees a lower likelihood of a competing bidder emerging, Kumar tells investors, adding that he expects both RenaissanceRe (RNR) and Axis Capital (AXS) to trade up on the deal news.

TODAY'S FREE FLY STORIES

SYMC

Symantec

$19.97

-0.595 (-2.89%)

08:04
10/19/18
10/19
08:04
10/19/18
08:04
Initiation
Symantec initiated  »

Symantec initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 06

    Dec

GNTX

Gentex

$18.62

-0.32 (-1.69%)

08:04
10/19/18
10/19
08:04
10/19/18
08:04
Earnings
Gentex reports Q3 EPS 42c, consensus 42c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 29

    Oct

AMRX

Amneal Pharmaceuticals

$18.51

0.02 (0.11%)

08:04
10/19/18
10/19
08:04
10/19/18
08:04
Hot Stocks
Amneal Pharmaceuticals receives FDA approval for generic version of BiCNU »

Amneal Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

  • 28

    Feb

BWA

BorgWarner

$36.92

-0.96 (-2.53%)

08:04
10/19/18
10/19
08:04
10/19/18
08:04
Hot Stocks
BorgWarner CFO Ronald Hundzinski retiring, Thomas McGill appointed interim CFO »

BorgWarner appointed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

ETFC

E-Trade

$48.89

-1.68 (-3.32%)

08:03
10/19/18
10/19
08:03
10/19/18
08:03
Recommendations
E-Trade analyst commentary  »

E-Trade price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRNS

Varonis

$64.72

-0.935 (-1.42%)

08:02
10/19/18
10/19
08:02
10/19/18
08:02
Initiation
Varonis initiated  »

Varonis initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 01

    Nov

  • 13

    Nov

LLNW

Limelight Networks

$5.07

0.12 (2.42%)

08:02
10/19/18
10/19
08:02
10/19/18
08:02
Recommendations
Limelight Networks analyst commentary  »

Limelight Networks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

DM

Dominion Energy Midstream

$18.39

0.04 (0.22%)

08:02
10/19/18
10/19
08:02
10/19/18
08:02
Hot Stocks
Dominion Energy Midstream raises quarterly cash distribution 5% to 36.90c »

The board of directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

DOCU

DocuSign

$46.26

-1.305 (-2.74%)

08:01
10/19/18
10/19
08:01
10/19/18
08:01
Initiation
DocuSign initiated  »

DocuSign initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

DIS

Disney

$116.26

-0.83 (-0.71%)

08:00
10/19/18
10/19
08:00
10/19/18
08:00
Upgrade
Disney rating change  »

Barclays sees Disney…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

AAPL

Apple

$215.98

-5.22 (-2.36%)

08:00
10/19/18
10/19
08:00
10/19/18
08:00
Options
Apple put buyer realizes 10% same-day gains »

Notable profits for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:00
10/19/18
10/19
08:00
10/19/18
08:00
Hot Stocks
Breaking Hot Stocks news story  »

Sentinel Energy Services…

PYPL

PayPal

$77.50

-2.61 (-3.26%)

08:00
10/19/18
10/19
08:00
10/19/18
08:00
Recommendations
PayPal analyst commentary  »

PayPal price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 13

    Nov

  • 13

    Nov

  • 26

    Nov

STNL

Sentinel Energy

$9.81

(0.00%)

08:00
10/19/18
10/19
08:00
10/19/18
08:00
Hot Stocks
Breaking Hot Stocks news story on Sentinel Energy »

Sentinel Energy Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$250.46

-8.44 (-3.26%)

07:58
10/19/18
10/19
07:58
10/19/18
07:58
Initiation
Adobe initiated  »

Adobe initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VLKAY

Volkswagen

$0.00

(0.00%)

, RNLSY

Renault

$0.00

(0.00%)

07:58
10/19/18
10/19
07:58
10/19/18
07:58
Periodicals
Volkswagen wins as EU set to back wifi over 5G, Reuters says »

Volkswagen (VLKAY) and…

VLKAY

Volkswagen

$0.00

(0.00%)

RNLSY

Renault

$0.00

(0.00%)

DDAIF

Daimler AG

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RDFN

Redfin

$16.49

-0.68 (-3.96%)

07:58
10/19/18
10/19
07:58
10/19/18
07:58
Recommendations
Redfin analyst commentary  »

Redfin price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

VRTX

Vertex

$179.00

-6.46 (-3.48%)

07:57
10/19/18
10/19
07:57
10/19/18
07:57
Hot Stocks
Vertex receives European CHMP positive opinion for KALYDECO »

Vertex Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 24

    Oct

PACB

Pacific Biosciences

07:57
10/19/18
10/19
07:57
10/19/18
07:57
Initiation
Pacific Biosciences initiated  »

Pacific Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

  • 06

    Nov

OZK

Bank OZK

$34.85

-1.57 (-4.31%)

07:57
10/19/18
10/19
07:57
10/19/18
07:57
Downgrade
Bank OZK rating change  »

Bank OZK downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 19

    Oct

  • 29

    Oct

IVZ

Invesco

$21.26

0.32 (1.53%)

07:57
10/19/18
10/19
07:57
10/19/18
07:57
Recommendations
Invesco analyst commentary  »

Invesco price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOXA

21st Century Fox

$45.81

-0.01 (-0.02%)

07:55
10/19/18
10/19
07:55
10/19/18
07:55
Initiation
21st Century Fox initiated  »

21st Century Fox…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

OCUL

Ocular Therapeutix

$6.17

-0.2 (-3.14%)

07:52
10/19/18
10/19
07:52
10/19/18
07:52
Hot Stocks
Ocular Therapeutix receives FDA warning letter related to ReSure sealant »

Ocular Therapeutix…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 28

    Dec

STT

State Street

$79.62

-2.5 (-3.04%)

07:52
10/19/18
10/19
07:52
10/19/18
07:52
Hot Stocks
State Street says on track to complete Beacon by early 2019 »

Says on track to complete…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

ENDP

Endo

$17.53

0.47 (2.76%)

07:52
10/19/18
10/19
07:52
10/19/18
07:52
Recommendations
Endo analyst commentary  »

Endo price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

  • 27

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.